The Beneficial Role of Vitamin D in Interstitial Cystitis

References (121)

1. 1 Peroxynitrite, a cloaked oxidant formed by nitric oxide and superoxide [DOI]
2. 2 Normal human urothelial cells in vitro: proliferation and induction of stratification.
3. 3 Vitamin D Receptor Negatively Regulates Bacterial-Stimulated NF-κB Activity in Intestine [DOI]
4. 4 1,25‐Dihydroxyvitamin D 3 Regulates the Synthesis of γ‐Glutamyl Transpeptidase and Glutathione Levels in Rat Primary Astrocytes [DOI]
5. 5 1,25-Dihydroxyvitamin D3 Reduces TGF-β3-Induced Fibrosis-Related Gene Expression in Human Uterine Leiomyoma Cells [DOI]
6. 6 1,25-Dihydroxyvitamin D3 inhibits lipopolysaccharide-induced immune activation in human endothelial cells [DOI]
7. 7 1,25-Dihydroxyvitamin D3 suppresses inflammation-induced expression of plasminogen activator inhibitor-1 by blocking nuclear factor-κB activation [DOI]
8. 8 Mast Cell Involvement in Interstitial Cystitis [DOI]
9. 9 Vitamin D Binding Protein-Macrophage Activating Factor (DBP-maf) Inhibits Angiogenesis and Tumor Growth in Mice [DOI]
10. 10 Increased Urine Histamine and Methylhistamine in Interstitial Cystitis [DOI]
11. 11 Mast Cell-Derived Histamine Mediates Cystitis Pain [DOI]
12. 12 Comparative effectiveness of vitamin D3 and dietary vitamin E on peroxidation of lipids and enzymes of the hepatic antioxidant system in Sprague--Dawley rats.
13. 13 Inflammatory Cell Types and Clinical Features of Interstitial Cystitis [DOI]
14. 14 Intravesical Nitric Oxide Production Discriminates Between Classic and Nonulcer Interstitial Cystitis [DOI]
15. 15 1,25D3 Enhances antitumor activity of gemcitabine and cisplatin in human bladder cancer models [DOI]
16. 16 1,25-dihydroxyvitamin D3 impairs NF-κB activation in human naïve B cells [DOI]
17. 17 Combination therapy with paricalcitol and trandolapril reduces renal fibrosis in obstructive nephropathy [DOI]
18. 18 Low Vitamin D Levels Correlate With the Proinflammatory State in Type 1 Diabetic Subjects With and Without Microvascular Complications [DOI]
19. 19 Effect of 1,25-dihydroxyvitamin D3, lipopolysaccharide, or lipoteichoic acid on the expression of NADPH oxidase components in cultured human monocytes [DOI]
20. 20 ONO-8130, a selective prostanoid EP1 receptor antagonist, relieves bladder pain in mice with cyclophosphamide-induced cystitis [DOI]
21. 21 Selective inhibition of cyclooxygenase‐2 (COX‐2) by 1α,25‐dihydroxy‐16‐ene‐23‐yne‐vitamin D 3 , a less calcemic vitamin D analog [DOI]
22. 22 The coupling of epidermal growth factor receptor down regulation by 1alpha,25-dihydroxyvitamin D3 to the hormone-induced cell cycle arrest at the G1-S checkpoint in ovarian cancer cells [DOI]
23. 23 Protective effect of aminoguanidine against oxidative stress and bladder injury in cyclophosphamide‐induced hemorrhagic cystitis in rat [DOI]
24. 24 Stimulated Release of Urine Histamine in Interstitial Cystitis [DOI]
25. 25 Histamine and mucosal mast cells in interstitial cystitis [DOI]
26. 26 1,25-Dihydroxyvitamin D3 down-regulation of HLA-DR on human peripheral blood monocytes.
27. 27 Sodium Pentosan Polysulfate Reduces Urothelial Responses to Inflammatory Stimuli Via an Indirect Mechanism [DOI]
28. 28 Abnormal urothelial HLA-DR expression in interstitial cystitis [DOI]
29. 29 The vitamin D receptor agonist elocalcitol upregulates L-type calcium channel activity in human and rat bladder [DOI]
30. 30 Gene expression profiles in dendritic cells conditioned by 1α,25-dihydroxyvitamin D3 analog [DOI]
31. 31 Serum transforming growth factor-beta levels in patients with vitamin D deficiency [DOI]
32. 32 Effects of l-arginine treatment on symptoms and bladder nitric oxide levels in patients with interstitial cystitis [DOI]
33. 33 Regulation of RANTES and IL‐8 production in normal human dermal fibroblasts by active vitamin D3 (tacalcitol) [DOI]
34. 34 Transient receptor potential A1 receptor‐mediated neural cross‐talk and afferent sensitization induced by oxidative stress: Implication for the pathogenesis of interstitial cystitis/bladder pain syndrome [DOI]
35. 35 Benefit of Satureja khuzestanica in subchronically rat model of cyclophosphamide-induced hemorrhagic cystitis [DOI]
36. 36 1,25-Dihydroxyvitamin D3 decreases the interferon-gamma (IFN-gamma) induced HLA-DR expression but not intercellular adhesion molecule 1 (ICAM-1) on human keratinocytes.
37. 37 Intramuscular injection of hrRANTES causes mast cell recruitment and increased transcription of histidine decarboxylase in mice: lack of effects in genetically mast cell‐deficient W/W V mice [DOI]
38. 38 The rat urinaryprostacyclin as well as other [DOI]
39. 39 1,25-Dihydroxyvitamin D3 inhibits secretion of interferon-γ by mitogen- and antigen-stimulated bovine mononuclear leukocytes [DOI]
40. 40 Expression of inducible nitric oxide synthase in primary culture of rat bladder smooth muscle cells by plasma from cyclophosphamide-treated rats [DOI]
41. 41 Cyclophosphamide suppresses thioredoxin reductase in bladder tissue and its adaptive response via inductions of thioredoxin reductase and glutathione peroxidase [DOI]
42. 42 Histamine receptors in human detrusor smooth muscle cells: physiological properties and immunohistochemical representation of subtypes [DOI]
43. 43 Water avoidance stress induces frequency through cyclooxygenase‐2 expression: A bladder rat model [DOI]
44. 44 Effects of dietary vitamin D deficiency on the cardiovascular system.
45. 45 Genome-based expression profiling study of Hunner’s ulcer type interstitial cystitis: an array of 40-gene model [DOI]
46. 46 1α,25‐Dihydroxy Vitamin D3 Modulation of HLA‐DR mRNA Induced by Gamma‐Interferon in Cultured Epithelial Tumor Cell Lines [DOI]
47. 47 Inhibitory effect of 1α,25-dihydroxyvitamin D3 on mast cell proliferation and A23187-induced histamine release, also accompanied by a decreased c-kit receptor [DOI]
48. 48 Oral treatment with a vitamin D3 analogue (BXL628) has anti‐inflammatory effects in rodent model of interstitial cystitis [DOI]
49. 49 Asociación del polimorfismo Fok I del gen del receptor de vitamina D (VDR) con concentraciones plasmáticas del factor transformador de crecimiento β1 interferón gamma en la diabetes mellitus tipo 1 [DOI]
50. 50 Impact of RANTES, MCP-1 and IL-8 in mast cells.
51. 51 Prostaglandins and Inflammation [DOI]
52. 52 Solar ultraviolet radiation effects on biological systems [DOI]
53. 53 Selective neutralization of prostaglandin E2 blocks inflammation, hyperalgesia, and interleukin 6 production in vivo. [DOI]
54. 54 The Mast Cell in Interstitial Cystitis: Role in Pathophysiology and Pathogenesis [DOI]
55. 55 Paricalcitol Inhibits Renal Inflammation by Promoting Vitamin D Receptor–Mediated Sequestration of NF-κB Signaling [DOI]
56. 56 A Comparison of Multiple Urine Markers for Interstitial Cystitis [DOI]
57. 57 Protective role of 1α, 25‐dihydroxyvitamin D3 against oxidative stress in nonmalignant human prostate epithelial cells [DOI]
58. 58 Vitamin D Induction of the Human Antimicrobial Peptide Cathelicidin in the Urinary Bladder [DOI]
59. 59 Obstruction-induced changes in urinary bladder smooth muscle contractility: a role for Rho kinase [DOI]
60. 60 The role of vitamin D in asthma [DOI]
61. 61 BLADDER EPITHELIAL CELLS FROM PATIENTS WITH INTERSTITIAL CYSTITIS PRODUCE AN INHIBITOR OF HEPARIN-BINDING EPIDERMAL GROWTH FACTOR-LIKE GROWTH FACTOR PRODUCTION [DOI]
62. 62 Increased iNOS Activity is Essential for Intestinal Epithelial Tight Junction Dysfunction in Endotoxemic Mice [DOI]
63. 63 1,25-Dihydroxyvitamin D Down-regulates Cell Membrane Growth- and Nuclear Growth-promoting Signals by the Epidermal Growth Factor Receptor [DOI]
64. 64 Evidence that vitamin D3 promotes mast cell–dependent reduction of chronic UVB-induced skin pathology in mice [DOI]
65. 65 The vitamin D receptor agonist elocalcitol inhibits IL‐8‐dependent benign prostatic hyperplasia stromal cell proliferation and inflammatory response by targeting the RhoA/Rho kinase and NF‐kB pathways [DOI]
66. 66 Vitamin D3 Upregulated Protein 1 Suppresses TNF-α–Induced NF-κB Activation in Hepatocarcinogenesis [DOI]
67. 67 EFFECTS OF VITAMIN D (CALCITRIOL) ON TRANSITIONAL CELL CARCINOMA OF THE BLADDER IN VITRO AND IN VIVO [DOI]
68. 68 Nutrient composition of the diet and the development of overactive bladder: A longitudinal study in women [DOI]
69. 69 1-α,25-Dihydroxyvitamin D3 regulates inducible nitric oxide synthase messenger RNA expression and nitric oxide release in macrophage-like RAW 264.7 cells [DOI]
70. 70 Increased vascular endothelial growth factor expression in patients with bladder pain syndrome/interstitial cystitis: its association with pain severity and glomerulations [DOI]
71. 71 BXL‐628, a vitamin D receptor agonist effective in benign prostatic hyperplasia treatment, prevents RhoA activation and inhibits RhoA/Rho kinase signaling in rat and human bladder [DOI]
72. 72 Increased Expression of Hypoxia-inducible Factor-1α and Vascular Endothelial Growth Factor Associated With Glomerulation Formation in Patients With Interstitial Cystitis [DOI]
73. 73 VDR-dependent regulation of mast cell maturation mediated by 1,25-dihydroxyvitamin D3 [DOI]
74. 74 Localization and Expression of Inducible Nitric Oxide Synthase in Biopsies From Patients With Interstitial Cystitis [DOI]
75. 75 Human detrusor smooth muscle cells release interleukin-6, interleukin-8, and RANTES in response to proinflammatory cytokines interleukin-1β and tumor necrosis factor-α [DOI]
76. 76 Serum Vitamin D and Risk of Bladder Cancer [DOI]
77. 77 NITRIC OXIDE AS AN OBJECTIVE MARKER FOR EVALUATION OF TREATMENT RESPONSE IN PATIENTS WITH CLASSIC INTERSTITIAL CYSTITIS [DOI]
78. 78 1,25(OH)2-Vitamin D3 Inhibits Proliferation and Decreases Production of Monocyte Chemoattractant Protein-1, Thrombopoietin, VEGF, and Angiogenin by Human Annulus Cells In Vitro [DOI]
79. 79 BCG Vaccination: A Role for Vitamin D? [DOI]
80. 80 POTENTIAL ROLE OF REL/NUCLEAR FACTOR-kappa B IN THE PATHOGENESIS OF INTERSTITIAL CYSTITIS [DOI]
81. 81 Followup of Patients With Interstitial Cystitis Responsive to Treatment With Intravesical Bacillus Calmette-Guerin or Placebo [DOI]
82. 82 Inhibition of angiogenesis by vitamin D-binding protein: Characterization of anti-endothelial activity of DBP-maf [DOI]
83. 83 Vitamin D metabolites and analogs induce lipoxygenase mRNA expression and activity as well as reactive oxygen species (ROS) production in human bone cell line [DOI]
84. 84 Vitamin D3 signalling to mast cells: A new regulatory axis [DOI]
85. 85 Quantitative Proteomics Identifies a β-Catenin Network as an Element of the Signaling Response to Frizzled-8 Protein-Related Antiproliferative Factor [DOI]
86. 86 CONCENTRATIONS OF SPECIFIC EPITHELIAL GROWTH FACTORS IN THE URINE OF INTERSTITIAL CYSTITIS PATIENTS AND CONTROLS [DOI]
87. 87 PENTOSANPOLYSULFATE INHIBITS MAST CELL HISTAMINE SECRETION AND INTRACELLULAR CALCIUM ION LEVELS:: AN ALTERNATIVE EXPLANATION OF ITS BENEFICIAL EFFECT IN INTERSTITIAL CYSTITIS [DOI]
88. 88 CYTOKINE REPERTOIRE OF EPITHELIAL CELLS LINING THE HUMAN URINARY TRACT [DOI]
89. 89 1,25-(OH2)D3 Alters the Transforming Growth Factor β Signaling Pathway in Renal Tissue [DOI]
90. 90 Effects of a vitamin D 3 analogue in a rat model of bladder outlet obstruction [DOI]
91. 91 NITRIC OXIDE: A USEFUL GAS IN THE DETECTION OF LOWER URINARY TRACT INFLAMMATION [DOI]
92. 92 NF-?B-dependent gene expression of proinflammatory cytokines in T24 cells: possible role in interstitial cystitis [DOI]
93. 93 OVER EXPRESSION OF PLATELET-DERIVED ENDOTHELIAL CELL GROWTH FACTOR/THYMIDINE PHOSPHORYLASE IN PATIENTS WITH INTERSTITIAL CYSTITIS AND BLADDER CARCINOMA [DOI]
94. 94 1,25-Dihydroxyvitamin D 3 and Development of Tuberculosis in Cattle [DOI]
95. 95 Intravesical treatment of painful bladder syndrome: a systematic review and meta-analysis [DOI]
96. 96 Association of vitamin D receptors with the nuclear matrix of human and rat genitourinary tissues [DOI]
97. 97 Long-lasting breaches in the bladder epithelium lead to storage dysfunction with increase in bladder PGE2 levels in the rat [DOI]
98. 98 Ultraviolet B Irradiance and Incidence Rates of Bladder Cancer in 174 Countries [DOI]
99. 99 Urinary epidermal growth factor is excreted from the rat isolated perfused kidney in the absence of plasma [DOI]
100. 100 An Immunohistochemical Study of Vitamin D Receptor Expression in Canine Cutaneous Mast Cell Tumours [DOI]
101. 101 1α,25-Dihydroxyvitamin D 3 Inhibits Angiogenesis In Vitro and In Vivo [DOI]
102. 102 1,25-Dihydroxyvitamin D 3 Induces Nitric Oxide Synthase and Suppresses Growth of Mycobacterium tuberculosis in a Human Macrophage-Like Cell Line [DOI]
103. 103 1α,25-dihydroxyvitamin D3 (Calcitriol) inhibits hypoxia-inducible factor-1/vascular endothelial growth factor pathway in human cancer cells [DOI]
104. 104 Regulation of Prostaglandin Metabolism by Calcitriol Attenuates Growth Stimulation in Prostate Cancer Cells [DOI]
105. 105 Calcitriol Is a Potent Inhibitor of Retinal Neovascularization [DOI]
106. 106 22-Oxa-1α,25-dihydroxyvitamin D 3 inhibits metastasis and angiogenesis in lung cancer [DOI]
107. 107 Activation of Bladder Mast Cells in Interstitial Cystitis: A Light and Electron Microscopic Study [DOI]
108. 108 1,25-Dihydroxyvitamin D3 activates secretion of hydrogen peroxide by human monocytes. [DOI]
109. 109 Prostaglandin E sub 2 −Induced Bladder Hyperactivity in Normal, Conscious Rats: Involvement of Tachykinins? [DOI]
110. 110 Human Bladder as a Novel Target for Vitamin D Receptor Ligands [DOI]
111. 111 1,25-Dihydroxyvitamin D3 Stimulates Phagocytosis but Suppresses HLA-DR and CD13 Antigen Expression in Human Mononuclear Phagocytes [DOI]
112. 112 Effect of vitamin D3in reducing metabolic and oxidative stress in the liver of streptozotocin-induced diabetic rats [DOI]
113. 113 Evidence for Urothelial Cell Activation in Interstitial Cystitis [DOI]
114. 114 Urothelial expression of neuropilins and VEGF receptors in control and interstitial cystitis patients [DOI]
115. 115 VEGF receptors and neuropilins are expressed in the urothelial and neuronal cells in normal mouse urinary bladder and are upregulated in inflammation [DOI]
116. 116 Phase IIb, Multicenter, Double-blind, Randomized, Placebo-controlled, Parallel-group Study to Determine Effects of Elocalcitol in Women With Overactive Bladder and Idiopathic Detrusor Overactivity [DOI]
117. 117 Mechanism of antimitogenic action of vitamin D in human colon carcinoma cells: relevance for suppression of epidermal growth factor-stimulated cell growth.
118. 118 The synthesis and release of prostaglandins by human urinary bladder muscle in vitro.
119. 119 Evaluation of health-related quality of life in patients with painful bladder syndrome/interstitial cystitis and the impact of four treatments on it [DOI]
120. 120 Vitamin D ameliorates stress ligand expression elicited by free fatty acids in the hepatic stellate cell line LX-2 [DOI]
121. 121 The efficacy and safety of intravesical Bacillus-Calmette-Guerin in the treatment of female patients with interstitial cystitis: a double-blinded prospective placebo controlled study.

Cited by 0

No indexed citations yet.

Related research

• A Short Questionnaire for Assessment of Dietary Vitamin D Intake — shares topic coverage
• Physicochemical Characterization of a Liposomal Formulation Based on Glucosamine and Vitamin D, Commercialized as a Nutritional Supplement — shares topic coverage
• Serum Vitamin D Levels and Severity of Asthma in Children — shares topic coverage
• Vitamin D Receptor BsmI Gene Polymorphisms and Gestational Diabetes Mellitus: A Saudi Study — shares topic coverage
• Nutrition and Oral Health: A Mini Review — shares topic coverage